跳至主要内容
临床试验/ACTRN12615000266561
ACTRN12615000266561进行中(未招募)3 期

A randomised controlled multicentre trial to evaluate the effect of imiquimod versus radiotherapy on treatment failure at 6 months in patients with lentigo maligna (LM) for which staged surgical excision with 5mm margins is not possible, is refused, or fails.

Melanoma and Skin Cancer (MASC) Trials0 个研究点目标入组 126 人开始时间: 2015年3月20日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Aged 18 years or older.
  • 2.A biopsy-proven LM. This includes previous treatment failures (not with imiquimod or RT) of LM that are diagnosed as biopsy-proven LM.
  • 3.LM that is in a location amenable to treatment with imiquimod and radiotherapy.
  • 4.Willing and able to comply with study requirements.
  • 5.Written informed consent.

排除标准

  • 1.Invasive melanoma.
  • 2.Medical or psychiatric condition that compromises the ability of the patient to complete protocol treatment or follow-up assessments.
  • 3.Patients who are pregnant or lactating. Women of child bearing potential must have a confirmed negative urine pregnancy test at study entry.
  • 4.Life expectancy of less than 2 years.
  • 5.Radiotherapy sensitivity syndrome

研究者

发起方
Melanoma and Skin Cancer (MASC) Trials

相似试验